ARTICLE | Top Story
Amgen lifts guidance, beats estimates
October 29, 2015 2:41 AM UTC
Amgen Inc. (NASDAQ:AMGN) raised its 2015 guidance and reported 3Q15 revenues above consensus estimates.
The company said it now expects 2015 revenue of $21.4-$21.6 billion, up from $21.1-$21.4 billion, and estimated 2015 non-GAAP EPS of $9.95-$10, up from $9.55-$9.80. Amgen also reported full year 2016 revenue guidance of $21.7-$22.3 billion and non-GAAP EPS of $10.35-$10.75. ...